Oravax inks oral COVID-19 vaccine supply deal amid talks about public listing

Oravax Medical has taken an early step toward the commercialization of its oral COVID-19 vaccine by entering into a deal to ship 10 million doses of the clinical-phase candidate to Southeast Asia.

Related Keywords

Vietnam ,Republic Of ,Malaysia ,Philippines ,Indonesia ,Thailand ,Singapore , ,Tan Thanh Holdings ,Tan Thanh Holdings Investment Joint Stock Company ,Oravax Medical ,Thanh Holdings ,Southeast Asian ,Oramed ,Southeast Asia ,Covid 19 ,Coronavirus ,Oral Vaccines ,Virus Like Particle ,Drug Delivery ,